In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Globus Medical (GMED – Research Report). The ...

Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of $101.00. The company’s shares closed yesterday at ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers. The medical ...

Globus Medical had a net margin of 4.09% and a return on equity of 10.83%. The firm had revenue of $657.29 million during the quarter, compared to analysts’ expectations of $646.19 million.

AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) will present its latest advancements in orthopedic technology at the 2025 ...

Globus Medical, Inc. (NYSE:GMED – Free Report) – Research analysts at Roth Capital lowered their Q1 2025 earnings estimates for Globus Medical in a research report issued to clients and ...

Across the recent three months, 11 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...

Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus ALIF blades. The Cohere space is the first porous ...

Globus Medical, Inc. has announced the commercial launches of two innovative products aimed at enhancing spine surgery: the COHERE™ ALIF Spacer and Modulus™ ALIF Blades. The COHERE™ ALIF ...

AUDUBON, Pa. - Globus Medical, Inc. (NYSE: GMED), a prominent musculoskeletal technology company with a market capitalization of $10.08 billion and impressive revenue growth of 60.62% in the last ...